Skip navigation
    Canada
    Canada
    Flag of the United States of America US
    News Releases Signup for News Alerts Media Contacts Executive Bios Corporate Fact Sheet BMO Expert Insights
    Navigation skipped

    News Releases

    Harris Nesbitt to Webcast Investor Conference on the Healthcare Industry  

    Harris Nesbitt, the U.S. investment banking arm of BMO Financial Group, is proud to present its 4th annual conference on the Healthcare industry starting on Wednesday, December 8 at 8:00 a.m. at The Metropolitan Club in New York City. 

    The institutional investor event brings together more than 50 leading and emerging companies in the pharmaceutical, biotechnology, life sciences and medical technology industries. Hosted by Harris Nesbitt equity research analysts John Boris (pharmaceuticals), Thomas Shrader (biotechnology) and Joanne Wuensch (medical technologies and devices), the event features a unique mix of company presentations followed by an interactive question and answer period.

    All presentations will be webcast live and can be accessed at:

    www.harrisnesbitt.com/conferences/healthcare2004

    Scheduled presenters and times are*:

    Time

    Track 1

    Track 2

    Track 3

    Track 4

    Track 5

    8:00 a.m.

    Nabi Biopharmaceuticals (NABI)

    Mark Smith, SVP Finance, Treasurer & CFO

    Stryker (SYK)

    John Brown, Chairman & CEO

    Medtronic (MDT)

    Rachel Scherer, VP, IR

    Curis (CRIS) Daniel, Passeri, President & CEO

    Michael Gray, VP Finance & CFO

    LCA Vision (LCAV)

    Alan Buckey, EVP, Finance

    8:45

    Dyax (DYAX)

    Henry Blair, Chairman, President & CEO

    St. Jude Medical (STJ)

    Laura Merriam, Director, IR

    Inhibitex (INHX)

    Joseph Patti, VP, Preclinical Dev., CSO

    Russell Plumb, CFO & VP of Finance & Admin

    Integra LifeSciences (IART)

    Gerry Carlozzi, EVP & COO

    CryoCath Technologies (CYT)

    Steven Arless, President & CEO

    9:30

    Genzyme (GENZ)

    Elliot Hillback, SVP Corp. Affairs

    Alcon (ACL)

    Kurtis Klein, VP, General Manager Consumer Products Div.

    Oscient (OSCI)

    Steven Rauscher, CEO & President

    Cortex Pharmaceuticals

    (COR)

    Roger Stoll, Chairman, President & CEO

    Aphton (APHT)

    Patrick Mooney, President & CEO

    10:15

    Alexion (ALXN)

    Lenny Bell, CEO

    Discovery Labs (DSCO)

    Robert Capetola, President & CEO

    ArthroCare (ARTC)

    Michael Baker, President & CEO

    Fernando Sanchez, SVP & CFO

    Conceptus (CPTS)

    Gregory Lichtwardt, EVP, Treasurer & CFO

    Kosan (KOSN)

    Robert Johnson, Jr. EVP, Development & Chief Medical Officer

    Time

    Track 1

    Track 2

    Track 3

    Track 4

    Track 5

    11:00

    Gilead Sciences (GILD)

    Mark Perry, Sr. Business Advisor

    Zimmer (ZMH)

    Raymond Elliott, Chairman, President & CEO

    Advanced Medical Optics (AVO)

    Russ Trenary, Corp. VP & Chief Marketing Officer

    Sheree Aronson, VP Corp. Comm & IR

    Northfields Labs (NFLD)

    Steven Gould, Chairman & CEO

    Praecis (PRCS)

    Kevin McLaughlin, President, COO & Director

    11:45

    Vertex (VRTX)

    Ian Smith, SVP & CFO

    Eyetech (EYET)

    David Guyer, CEO

    ResMed (RMD)

    David Pendarvis, VP Global General Counsel

    CardioDynamics (CDIC)

    Michael Perry, CEO & Director

    AMN Healthcare (AHS)

    Susan Nowakowski, President & COO

    12:30

    Tercica (TRCA)

    Tim Lynch, CFO

    Ross Clark, CTO and Founder

    Cubist (CBST)

    Mike Bonney, President & CEO

    Respironics (RESP)

    John Miclot, President & CEO

    Dan Bevevino, VP & CFO

    Oxigene

    Frederick Driscoll, President & CEO

    Keryn Biopharmaceuticals Inc.

    Michael Weiss, Chairman & CEO

    1:15

    Vicuron (MICU)

    Dov Goldstein, EVP, Finance & CFO

    TriPath Imaging (TPTH)

    Stephen Hall, CFO & SVP

    QLT (QLTI)

    Mohammed Azab, EVP Research & Development & CMO

    Allied Healthcare (AHCI)

    Sarah Eames, EVP

    Indevus (IDEV)

    Michael Rogers, EVP & CFO

    2:00

    Chiron (CHIR)

    Joel Jung, VP & Treasurer

    Mannkind (MNKD)

    Hakan Edstrom, President, COO & Director

    Bausch & Lomb (BOL)

    Stephen McCluski, SVP & CFO

    Barbara Kelley, Director, IR

    Daniel Ritz, Director, IR

    Vivus (VVUS)

    Leland Wilson, President & CEO

    Timothy Morris, VP of Finance & CFO

    Emisphere Technologies (EMIS)

    Michael Goldberg, CEO

    2:45

    InterMune (ITMN)

    Norman Halleen, SVP Finance & CFO

    Steven Porter, SVP Clinical Affairs

    AVANT Immunotherapeutics

    Avery Caitlin, SVP & CFO

    AnorMED (AOM)

    Michael Abrams,

    President & CEO

    Cross Country (CCRN)

    Joseph Boshart, President & CEO

    Howard Goldman, Director, IR

    Concept Therapeutics (CORT)

    Fred Kurland, CFO

    *Agenda subject to change.

    About Harris Nesbitt

    Harris Nesbitt is an investment and corporate bank offering clients access to a full range of products and services including investment and corporate banking, treasury services, market risk management, institutional investing and research. Harris Nesbitt is part of Harris, an integrated financial services organization providing more than 1.5 million personal, business, corporate and institutional clients with banking, lending, investing and financial management solutions. Harris is a member of BMO Financial Group (NYSE, TSX: BMO). For more information, please visit www.harrisnesbitt.com.

    - 30 -

    For further information: